Ecdysteroids (Ecs) enhance the formation of Ec receptor–ultraspiracle protein (EcR–USP) heterodimers which regulate gene transcription. To study EcR–USP heterodimerization, fusion proteins were constructed from the LBDs (ligand-binding domains) of Drosophila EcR or USP and the activation or DNA-binding region of GAL4 respectively. Reporter gene (lacZ) activation was fully dependent on the co-expression of the two fusion proteins and thus constitutes a reliable measure for the interaction in vivo between the two LBDs in the yeast cell. To identify structures involved in heterodimerization, a total of 27 point mutations were generated in the EcR and USP LBDs at selected sites. Heterodimerization and its inducibility by ligand were mainly affected by mutations in the dimerization interface and in the ligand-binding pocket of EcR respectively. However, also mutations not located in these structures or even in the LBD of USP influenced ligand-dependent heterodimerization. Together with previously reported ligand-binding studies, the existence of such local, intra- and inter-molecular mutation effects suggest that ligand-induced dimerization results from a synergistic interaction between ligand-binding and heterodimerization functions in EcR LBD, and that it depends on global features of the LBDs of EcR and USP and on their mutual surface compatibility.
Abbreviations used: Ec, ecdysteroid; EcR, Ec receptor; USP, ultraspiracle protein; LBD, ligand-binding domain; DIF, dimerization interface; LBP, ligand-binding pocket; MT, ‘mouse-trap’; RXR, 9-cis-retinoic acid receptor; RAR, retinoic acid receptor; Eflig, ligand effect; M.U., Miller units.
Both authors contributed equally to this work.
Present address: Affibody AB, P.O. Box 201 37, SE-161 02 Bromma, Sweden.
Permanent address: Institute for Health, Science and Society, University of North Carolina, Greensboro, NC 27402, U.S.A.